Skip to content

The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis

The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02520401
Enrollment
22
Registered
2015-08-11
Start date
2015-10-31
Completion date
2018-12-31
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-implantitis

Brief summary

This studies aims to investigate the effect of a probiotics in peri-implantitis patients as an adjunct to non-surgical therapy.

Detailed description

This studies aims to investigate the effect of a probiotics in peri-implantitis patients as an adjunct to non-surgical therapy. Study design: This study will be a single centre (Department of Oral Health Sciences, University Hospitals Leuven), double blind randomized, placebo controlled clinical trial. The randomization (by means of a computer program) and double blind design are thought to minimize the bias of the investigator and patients. Selection of the study population: Adults, who consult at the departement of Periodontology at the University Hospital Leuven, with peri-implantitis and who fit the inclusion criteria will be asked to participate in this study.

Interventions

OTHERProbiotic - BioGaia

Use of a probiotic tablet

OTHERPlacebo

Use of a placebo tablet

Sponsors

BioGaia AB
CollaboratorINDUSTRY
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* \>18 years of age * Patients with at least one implant\* diagnosed with initial peri-implantitis. * Willing and able to give written informed consent * No signs of acute periodontitis * presence of keratinized tissue around treated implant(s)

Exclusion criteria

* patients who smoke * patients with periodontitis * pregnant or lactating woman * patients with poorly controlled diabetes * patients taking bisphosphonate mediation * patient who had taken systemic antibiotics 3 months prior to treatment * peri-implantitis treatment 12 months prior intake

Design outcomes

Primary

MeasureTime frameDescription
Probing Pocket Depth (PPD) at peri-implantitis sitesBaseline - 6 monthsPocket probing depth measured with Merrit-B probe

Secondary

MeasureTime frameDescription
Bleeding on Probing (BoP) at peri-implantitis sitesBaseline - 6 monthsBinairy outcome: 0: no bleeding, 1: bleeding
Plaque at peri-implantitis sitesBaseline - 6 monthsBinairy outcome: 0: no plaque, 1: plaque
Microbial samplesBaseline - 6 monthsOf tongue coating, saliva and peri-implantitis site
Full mouth plaque score (FMPS)Baseline - 6 monthsBinairy outcome: 0: no plaque, 1: plaque

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026